1-17 of 17
Deborah Stephens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of sequencing of CART vs bi-specific antibody on survival in relapsed/refractory large B-cell lymphoma: An analysis from the ABC consortium

Free
Max Kelsten, Colin Thomas, Yun Kyoung Tiger, Ari Pelcovits, Adam Kidwell, Matthew Cortese, James Davis, Deborah Stephens, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Vaishalee Kenkre, Brian Hess, Megan Herr, Geoffrey Shouse, Thomas Ollila, Daniel Antonio, Alexandra Noveihed, Omar Elghawy, Alan Kerr, Jonathan Moreira, Shuo Ma, Jane Winter, Nirav Shah, Leo Gordon, Narendranath Epperla, Natalie Grover, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 398.
https://doi.org/10.1182/blood-2025-398
Published: 2025
Journal Articles

Real-world outcomes of younger patients with chronic lymphocytic leukemia treated with first-line BTK inhibitor or BCL2 inhibitor therapy

Free
Hannah Willis, Joshua Horns, Kelsey Baron, Allison Bock, Lindsey Fitzgerald, Narendranath Epperla, Harsh Shah, Boyu Hu, Deborah Stephens, Adam Kittai, Daniel Ermann
Journal: Blood
Blood (2025) 146 (Supplement 1): 6316.
https://doi.org/10.1182/blood-2025-6316
Published: 2025
Journal Articles

Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience

Free
Christopher Jensen, Mazyar Shadman, Andres Chang, Nicole Lamanna, Beenish Manzoor, Chaitra Ujjani, Deborah Stephens, Wendy Sinai, Brian Hill, Jennifer Brown, Hande Tuncer, Matthew S Davids, Toby Eyre, Nicolas Martinez-Calle, Lori Leslie, Lindsey Roeker, Paul Barr, Nnadozie Emechebe, Alan Skarbnik, Bita Fakhri, Meghan Thompson, Joanna Rhodes, Isabelle Fleury, Frederick Lansigan, Robson Lima, Zhu Cui, Michael Coyle, Samin Houshyar, Laurie Pearson, Irina Pivneva, Talissa Watson, Annie Guerin, Nilanjan Ghosh
Journal: Blood
Blood (2025) 146 (Supplement 1): 3885.
https://doi.org/10.1182/blood-2025-3885
Published: 2025
Journal Articles

CLL bone marrow infiltration is associated with osteocyte loss and adipose tissue fragmentation: A high-resolution imaging study

Free
In Kyu Lee, Yoshihiro Obata, Anthony Pomicter, Justin Williams, Bejal Kikani, Christopher Jensen, Douglas Sborov, Claire Acevedo, Deborah Stephens
Journal: Blood
Blood (2025) 146 (Supplement 1): 3179.
https://doi.org/10.1182/blood-2025-3179
Published: 2025
Journal Articles

Bispecific antibody vs non-bispecific antibody systemic therapy as immediate next line treatment after chimeric antigen receptor T-cell (CART) failure in large B-cell lymphoma

Free
Kyle Miyazaki, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Ari Pelcovits, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Vaishalee Kenkre, Megan Herr, Thomas Ollila, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Nour Nassour, Omar Elghawy, Jonathan Moreira, Adit Dharia, Salmaan Mubeen, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Narendranath Epperla, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 4502.
https://doi.org/10.1182/blood-2025-4502
Published: 2025
Journal Articles

Real-world changes in CLL treatment patterns following collaborative educational initiatives delivered in community settings

Free
Carmine Deluca, Michael Beyer, Marina Wanes, Catherine Coombs, Deborah Stephens, Lee Jamison, Javier Pinilla-Ibarz, Meghan Thompson, Nitin Jain, Brett Blum, Hejiang Wu, Renee Pearl
Journal: Blood
Blood (2025) 146 (Supplement 1): 6430.
https://doi.org/10.1182/blood-2025-6430
Published: 2025
Journal Articles

Updates of R/R CLL with prior exposure to Bruton's tyrosine kinase (BTK) inhibitor and/or bcl-2 inhibitor in the Phase 1 trial of LP-168 (Rocbrutinib), a novel COVALENT and non-COVALENT BTK inhibitor

Free
Jennifer Woyach, Danielle Brander, Boyu Hu, Kerry Rogers, Zulfa Omer, Emily Curran, Deborah Stephens, Andrea Sitlinger, Yi Chen, Stephen Anthony, Yu Chen, Kewei Shang, John Byrd
Journal: Blood
Blood (2025) 146 (Supplement 1): 87.
https://doi.org/10.1182/blood-2025-87
Published: 2025
Journal Articles

Real-world outcomes with bispecific antibody therapies for aggressive B-cell lymphomas in octogenarians

Free
Lindsey Fitzgerald, Elena Nazarenko, Yizhe Xu, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Ari Pelcovits, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Kyle Miyazaki, Jonathon Cohen, Megan Melody, Daniel Kerr, Vaishalee Kenkre, Thomas Ollila, Megan Herr, Salmaan Mubeen, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Reem Karmali, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 3746.
https://doi.org/10.1182/blood-2025-3746
Published: 2025
Journal Articles

Infections in patients with aggressive B-cell lymphomas treated with CD3xCD20 bispecific antibodies

Free
Daniel Reef, Nicole Altomare, Colin Thomas, Salmaan Mubeen, Yun Kyoung Tiger, Ari Pelcovits, Thomas Ollila, Victoria Gill, Adam Kidwell, Matthew Cortese, James Davis, Deborah Stephens, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Adit Dharia, Megan Melody, Vaishalee Kenkre, Brian Hess, Megan Herr, Geoffrey Shouse, Nirav Shah, Narendranath Epperla, Tessa Andermann, Reem Karmali, Natalie Grover
Journal: Blood
Blood (2025) 146 (Supplement 1): 2709.
https://doi.org/10.1182/blood-2025-2709
Published: 2025
Journal Articles

Updated results from a Phase II study of minimal residual disease-guided venetoclax + obinutuzumab for the initial treatment of fit patients with chronic lymphocytic leukemia

Free
Meghan Thompson, Anthony Mato, Andrew Zelenetz, Jae Park, Mark Geyer, Andriy Derkach, David Nemirovsky, Deborah Stephens, Catherine Coombs, Prioty Islam, Christopher Jensen, Lorenzo Falchi, Lia Palomba, Anita Kumar, Gilles Salles, Eytan Stein, Jennifer Lue, Lauren Nogan, Bejal Kikani, Ryan Sutterby, Thu Quynh Nguyen, Alexandra Allen, Sumathy Sudhir, Gail Panton, Victoria Duffy, Dianna Tyznar, Jamila Brutus, Tenzin Nyima, Anmol Shah, Dhara Soni, Michael Silvestrone, Monica Shah, Miranda Harris, Megha Karnam, Claire Hutzler, Kevin David, Aaron Goldberg, Stephen Fleming, Giovanni Diaz, Habib Hamidi, Bita Fakhri, Lindsey Roeker
Journal: Blood
Blood (2025) 146 (Supplement 1): 3902.
https://doi.org/10.1182/blood-2025-3902
Published: 2025
Journal Articles

Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic leukemia

Free
Jennifer Huang, Jenna Voutsinas, Niranjan Khaire, Vincenzo Pizzuti, Leyla Shune, Matthew Lei, Rodrigo Fonseca, Mohammad Ammad Ud Din, Alan Skarbnik, Agrima Mian, Sushma Bharadwaj, Aseel Alsouqi, Bret Wankel, Graham Wehmeyer, Joseph Lukowski, Alexey Danilov, Tanya Siddiqi, Meghan Thompson, Michael Scordo, Stephanie Franco, Deborah Stephens, Chaitra Ujjani, Ryan Lynch, Jordan Gauthier, William Wierda, Paul Barr, Adam Kittai, Jonah Shulman, Matthew Lunning, Kerry Rogers, Bita Fakhri, Brian Hill, Javier Pinilla-Ibarz, Talal Hilal, Jacob Soumerai, Manali Kamdar, Qian Wu, Nitin Jain, Mazyar Shadman
Journal: Blood
Blood (2025) 146 (Supplement 1): 798.
https://doi.org/10.1182/blood-2025-798
Published: 2025
Journal Articles

PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course

Free
Zhu Cui, Angie Mae Rodday, Hocine Tighiouart, Nicholas Counsell, Sara Rossetti, Jenica Upshaw, Amy Kirkwood, Hongli Li, Ranjana Advani, Olivier Casasnovas, James Cerhan, Massimo Federico, Andrea Gallamini, Herve Ghesquieres, Eliza Hawkes, David Hodgson, Martin Hutchings, Peter Johnson, Brian Link, Eric Mou, John Radford, Kerry Savage, Deborah Stephens, Pier Luigi Zinzani, Matthew Maurer, Cedric Rossi, Andrew Evens, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 129.
https://doi.org/10.1182/blood-2025-129
Published: 2025
Journal Articles

Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium

Free
Victoria Gill, Ari Pelcovits, Thomas Ollila, Lindsey Fitzgerald, Narendranath Epperla, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Alexandra Noveihed, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Kyle Miyazaki, Jonathon Cohen, Megan Melody, Adit Dharia, Vaishalee Kenkre, Megan Herr, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 960.
https://doi.org/10.1182/blood-2025-960
Published: 2025
Journal Articles

Real world comparison of commercial CAR T-cell constructs for the treatment of LBCL

Free
Megan Melody, Alan Kerr, Megan Herr, Adit Dharia, Nicole Altomare, Natalie Grover, Colin Thomas, Omar Elghawy, Yun Kyoung Tiger, Alexandra Noveihed, Ari Pelcovits, Thomas Ollila, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Nikesh Shah, David Swoboda, Vaishalee Kenkre, Geoffrey Shouse, Daniel Antonio, Deborah Stephens, Nirav Shah, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Narendranath Epperla, Reem Karmali, Brian Hess
Journal: Blood
Blood (2025) 146 (Supplement 1): 781.
https://doi.org/10.1182/blood-2025-781
Published: 2025
Journal Articles

Outcomes of patients with Relapsed/Refractory aggressive B-cell lymphoma receiving bispecific antibody therapy as monotherapy or in combination with targeted therapy

Free
Timothy Oh, Ari Pelcovits, Natalie Grover, Colin Thomas, Yun Kyoung Tiger, Matthew Cortese, James Davis, Adam Kidwell, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Megan Melody, Nikesh Shah, Vaishalee Kenkre, Brian Hess, Thomas Ollila, Megan Herr, Geoffrey Shouse, Salmaan Mubeen, Omar Elghawy, Daniel Antonio, Daniel Kerr, Calvin Lee, Jonathan Moreira, Shuo Ma, Jane Winter, Nirav Shah, Leo Gordon, Narendranath Epperla, Deborah Stephens, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 4551.
https://doi.org/10.1182/blood-2025-4551
Published: 2025
Journal Articles

Socioeconomic disadvantage, as measured by area deprivation index (ADI), impacts survival in patients with relapsed/refractory aggressive lymphoma treated with CART

Free
Daniel Antonio, Tarneka Manning, Natalie Grover, Colin Thomas, Ari Pelcovits, Matthew Cortese, James Davis, Tamara Moyo, Lindsey Fitzgerald, Jonathon Cohen, Vaishalee Kenkre, Megan Herr, Deborah Stephens, Geoffrey Shouse, Jonathan Moreira, Shuo Ma, Jane Winter, Leo Gordon, Brian Hess, Narendranath Epperla, Reem Karmali
Journal: Blood
Blood (2025) 146 (Supplement 1): 6281.
https://doi.org/10.1182/blood-2025-6281
Published: 2025
Journal Articles

PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD

Free
Clinical Trials & Observations
Bradley M. Haverkos, Diana Abbott, Mehdi Hamadani, Philippe Armand, Mary E. Flowers, Reid Merryman, Manali Kamdar, Abraham Sebastian Kanate, Ayman Saad, Amitkumar Mehta, Siddhartha Ganguly, Timothy S. Fenske, Parameswaran Hari, Robert Lowsky, Leslie Andritsos, Madan Jagasia, Asad Bashey, Stacey Brown, Veronika Bachanova, Deborah Stephens, Shin Mineishi, Ryotaro Nakamura, Yi-Bin Chen, Bruce R. Blazar, Jonathan Gutman, Steven M. Devine
Journal: Blood
Blood (2017) 130 (2): 221–228.
https://doi.org/10.1182/blood-2017-01-761346
Published: 2017
Includes: Supplemental data